Tumor hypoxia and microscopic diffusion capacity in brain tumors: A comparison of 62Cu-Diacetyl-Bis (N4-Methylthiosemicarbazone) PET/CT and diffusion-weighted MR imaging

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 41, Issue 7, 2014, Pages 1419-1427

  Hino Shishikura, Ayako ^a   Tateishi, Ukihide ^a   Shibata, Hirofumi ^a   Yoneyama, Tomohiro ^a   Nishii, Toshiaki ^a   Torii, Ikuo ^a   Tateishi, Kensuke ^a   Ohtake, Makoto ^a   Kawahara, Nobutaka ^a   Inoue, Tomio ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Diffusion weighted MR imaging; Glioma; MRI; PET CT

Indexed keywords

DIACETYL BIS (N4 METHYLTHIOSEMICARBAZONE) CU 62; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; COPPER (II) DIACETYL-DI(N(4)-METHYLTHIOSEMICARBAZONE); ORGANOMETALLIC COMPOUND; THIOSEMICARBAZONE DERIVATIVE;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN TUMOR; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; HYPOXIA; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; YOUNG ADULT; BRAIN NEOPLASMS; CELL HYPOXIA; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; DIFFUSION; METABOLISM; MULTIMODAL IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES;

ADULT; AGED; BRAIN NEOPLASMS; CELL HYPOXIA; DIFFUSION; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MULTIMODAL IMAGING; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; THIOSEMICARBAZONES; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84903692627     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-014-2714-x     Document Type: Article

References (31)

1. Graeber TG, Osmanian C, Jacks T, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature. 1996;379:88-91. (Pubitemid 26008141)
2. Shweiki D, Itin A, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843-5.
3. Jensen RL. Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. J Neurooncol. 2009;92:317-35.
4. Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986;161:401-7. (Pubitemid 17173295)
5. Warach S, Chien D, Li W, Ronthal M, et al. Fast magnetic resonance diffusion-weighted imaging of acute human stroke. Neurology. 1992;42:1717-23.
6. Pierpaoli C, Righini A, Linfante I, et al. Histopathologic correlates of abnormal water diffusion in cerebral ischemia: diffusion-weighted MR imaging and light and electron microscopic study. Radiology. 1993;189:439-48. (Pubitemid 23321425)
7. Khayal IS, Vandenberg SR, Smith KJ, et al. MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas. Neuro Oncol. 2011;13:1192-201.
8. Murakami R, Hirai T, Sugahara T, et al. Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one-versus two-parameter pilot method. Radiology. 2009;251:838-45.
9. Barajas Jr RF, Rubenstein JL, Chang JS, et al. Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma. Am J Neuroradiol. 2010;31:60-6.
10. Higano S, Yun X, Kumabe T, et al. Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology. 2006;241:839-46. (Pubitemid 46190551)
11. Hoigebazar L, Jeong JM. Hypoxia imaging agents labeled with positron emitters. Recent results. Cancer Res. 2012;194:285-99.
12. Fujibayashi Y, Taniuchi H, Yonekura Y, et al. Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential. J Nucl Med. 1997;38:1155-60. (Pubitemid 27339632)
13. Imam SK. Review of positron emission tomography tracers for imaging of tumor hypoxia. Cancer Biother Radiopharm. 2010;25:365-74.
14. Wen B, Burgman P, Zanzonico P, et al. A preclinical model for noninvasive imaging of hypoxia-induced gene expression; comparison with an exogenous marker of tumor hypoxia. Eur J Nucl Med Mol Imaging. 2004;31:1530-8. (Pubitemid 39592774)
15. Nunn A, Linder K, Strauss HW. Nitroimidazoles and imaging hypoxia. Eur J Nucl Med. 1995;22:265-80.
16. Martin GV, Caldwell JH, Graham MM, et al. Noninvasive detection of hypoxic myocardium using fluorine-18-fluoromisonidazole and positron emission tomography. J Nucl Med. 1992;33:2202-8.
17. Sheehan JP, Popp B, Monteith S, et al. Trans sodium crocetinate: functional neuroimaging studies in a hypoxic brain tumor. J Neurosurg. 2011;115:749-53.
18. Lewis JS, Sharp TL, Laforest R, et al. Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation. J Nucl Med. 2001;42:655-61. (Pubitemid 32298288)
19. Tateishi K, Tateishi U, Sato M, et al. Application of 62Cu-Diacetyl-Bis (N4-Methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1alpha expression in patients with glioma. Am J Neuroradiol. 2012;34:92-9.
20. Brat DJ, Van Meir EG. Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Invest. 2004;84:397-405. (Pubitemid 41656467)
21. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97-109. (Pubitemid 47103521)
22. Fujibayashi Y, Cutler CS, Anderson CJ, et al. Comparative studies of Cu-64-ATSM and C-11-acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in rats. Nucl Med Biol. 1999;26:117-21. (Pubitemid 29030531)
23. Read SJ, Jackson GD, Abbott DF, et al. Experience with diffusion-weighted imaging in an acute stroke unit. Cerebrovasc Dis. 1998;8:135-43. (Pubitemid 28192813)
24. Lewis JS, McCarthy DW, Welch MJ, et al. Evaluation of 64Cu-ATSM in vitro and in vivo in a tumor model. J Nucl Med. 1999;40:177-83. (Pubitemid 29044189)
25. Yuan H, Schroeder T, Bowsher JE, Dewhirst MW, et al. Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl- bis(N4-methylthiosemicarbazone). J Nucl Med. 2006;47:989-98. (Pubitemid 46939952)
26. Schlegel U, Schmidt-Wolf IG, Deckert M. Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment. J Neurol Sci. 2000;181:1-12.
27. Barlow CH, Harken AH, Chance B. Evaluation of cardiac ischemia by NADH fluroescence photography. Ann Surg. 1977;186:737-40. (Pubitemid 8250765)
28. Guo AC, Cummings TJ, Dash RC, et al. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology. 2002;224:177-83. (Pubitemid 34680392)
29. Matsushima N, Maeda M, Umino M, et al. Relation between FDG uptake and apparent diffusion coefficients in glioma and malignant lymphoma. Ann Nucl Med. 2012;26:262-71.
30. Buchbender C, Heusner TA, Lauenstein C, et al. Oncologic PET/MRI, Part 1: tumor of the brain, head and neck, chest, abdomen, and pelvis. J Nucl Med. 2012;53:928-38.
31. Buchbender C, Heusner TA, Lauenstein C, et al. Oncologic PET/MRI, Part 2: bone tumors, soft-tissue tumors, melanoma, and lymphoma. J Nucl Med. 2012;53:1244-52.